Skip to main content
. Author manuscript; available in PMC: 2017 Nov 15.
Published in final edited form as: Adv Drug Deliv Rev. 2016 Mar 17;106(Pt A):45–62. doi: 10.1016/j.addr.2016.03.003

Figure 5.

Figure 5

Basic properties of M13-SWCNT fluorescent-labeled nanocarrier; A) basic structure of the imaging vector: SWCNT is embedded in the pVIII structure and pIII is engineered to bind to prostate cancer; B) UV-absorption spectra at different wavelengths; C) comparison of PL excitation of M13-SWNTs in sodium cholate (SC) and phosphate-buffer saline (PBS); D) stability test of SWNTs in serum(Reprinted from ref.[54] Copyright (2016) American Chemical Society).